Publications by authors named "Mathieu Molimard"

Claim this Profile
I
Impact of Liquid Sublingual Immunotherapy on Health Care Resource Use in Allergic Rhinitis and Asthma in the Real-world EfficAPSI Study.
Philippe Devillier, Pascal Demoly, Jean-François Bergmann, Bertrand Delaisi, Amandine Gouverneur, Mathieu Molimard

J Investig Allergol Clin Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental protocols and models for assessing the permeation of antineoplastic drugs through gloves: From a scoping review to a guidelines proposition for future studies.
Guillaume Swierczynski, Joris Guyon, Mathieu Molimard, Alain Garrigou, Isabelle Baldi

J Hazard Mater· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a LC-MS/MS Method for Ripretinib and Its Metabolite: Example of a Journey From Laboratory Bench to Routine Application With a Greenness Assessment.
Cedric Rakotovao, Ahmad Sharanek, Audrey Burban, Paul Gueroue, Stéphane Bouchet, Mathieu Molimard

Biomed Chromatogr· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethics and clinical research: How can the Ethics Committees (CPPs) and Committees for Research Ethics (CER) evolve?
Driss Berdaï, Aurélie Guérin, David Pérol, Cécile Girault, Mathieu Molimard

Therapie· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Linkage of Electronic Medical Records and National Health Data System in Type 2 Diabetes Research: Methodological Insights and Implications.
Romane Le Goff, Sandrine Brice, Andrea Contini, Marjorie Boussac, Arnaud Souche, Mathieu Molimard

Pharmacoepidemiol Drug Saf· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to "Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)" [The Lancet Regional Health - Europe 41 (2024) 100915].
Pascal Demoly, Mathieu Molimard, Jean-François Bergmann, Bertrand Delaisi, Amandine Gouverneur

Lancet Reg Health Eur· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
The Cannabinoid Consumed Is Not Necessarily the One Expected: Recent Experience with Hexahydrocannabinol.
Joris Guyon, Camille Paradis, Karine Titier, Coralie Braganca, Alexandre Peyre, Mathieu Molimard

Cannabis Cannabinoid Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Driss Berdaï, Aurélie Guérin, David Pérol, Cécile Girault, Mathieu Molimard

Therapie· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the benefit-risk balance of drugs. Some lessons from the COVID pandemic.
Jean-Luc Cracowski, Mathieu Molimard, Vincent Richard, Matthieu Roustit, Charles Khouri

Expert Opin Drug Saf· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transition of care from adolescence to early adulthood in severe asthmatic patients treated with omalizumab in real life.
Camille Taillé, Marc Humbert, Arnaud Bourdin, Céline Thonnelier, Audrey Lajoinie, Mathieu Molimard

ERJ Open Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study).
Pascal Demoly, Mathieu Molimard, Jean-François Bergmann, Bertrand Delaisi, Amandine Gouverneur

Lancet Reg Health Eur· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A successful linkage of a named patient products of sublingual immunotherapy-dispensing registry to French healthcare insurance database (SNDS): methodological constitution of the EfficAPSI cohort.
Philippe Devillier, Mathieu Molimard, Jean-François Bergmann, Bertrand Delaisi, Amandine Gouverneur

Expert Rev Clin Immunol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Joëlle Micallef, Hervé Maisonneuve, Sophie Muller, Mathieu Molimard, Bernard Bégaud

Therapie· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What should be done to combat misinformation about health products?
Joëlle Micallef, Hervé Maisonneuve, Sophie Muller, Mathieu Molimard, Bernard Bégaud

Therapie· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why the article that led to the widespread use of hydroxychloroquine in COVID-19 should be retracted.
Damien Barraud, Lonni Besançon, Elisabeth M Bik, Eric Billy, Franck Clarot, Mathieu Molimard

Therapie· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with internal contamination of nurses by antineoplastic drugs based on biomonitoring data from a previous study.
Antoine Villa, Arna Geshkovska, Gauthier Bellagamba, Isabelle Baldi, Mathieu Molimard

Int J Hyg Environ Health· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minors and young adult's hospitalizations after "chimique" consumption in Mayotte Island: Which substances are involved?
Ruben Goncalves, Alexandre Peyré, Nadège Castaing, Thomas Beeken, Sophie Olivier, Mathieu Molimard

Therapie· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?
Antoine Pariente, Joëlle Micallef, Amir Lahouegue, Mathieu Molimard, Marine Auffret

Therapie· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Antoine Pariente, Joëlle Micallef, Amir Lahouegue, Mathieu Molimard, Marine Auffret

Therapie· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of paediatric and adult asthma patients.
Marc Humbert, Arnaud Bourdin, Camille Taillé, Driss Kamar, Céline Thonnelier, Mathieu Molimard

Eur Respir J· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urine biomonitoring of occupational exposure to methotrexate using a highly sensitive UHPLC-MS/MS method in MRM mode.
Antoine Villa, Kevin Tremolet, Béatrice Martinez, Murielle Petit, Xavier Dascon, Mathieu Molimard

J Chromatogr B Analyt Technol Biomed Life Sci· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A UPLC-MS/MS Method for Plasma Biological Monitoring of Nirmatrelvir and Ritonavir in the Context of SARS-CoV-2 Infection and Application to a Case.
Joris Guyon, Marine Novion, Virginie Fulda, Dominique Ducint, Mathieu Molimard

J Am Soc Mass Spectrom· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit-risk balance of COVID drugs. New prospects.
Jean-Luc Cracowski, Vincent Richard, Mathieu Molimard

Therapie· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib Optimized Therapy Improves Major Molecular Response Rates in Patients with Chronic Myeloid Leukemia.
Hyacinthe Johnson-Ansah, Benjamin Maneglier, Françoise Huguet, Laurence Legros, Martine Escoffre-Barbe, Mathieu Molimard

Pharmaceutics· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE).
Alexandre Duvignaud, Edouard Lhomme, Racha Onaisi, Rémi Sitta, Ambre Gelley, Mathieu Molimard

Clin Microbiol Infect· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis